LENZ Therapeutics Inc.

NASDAQ: LENZ · Real-Time Price · USD
37.83
-3.08 (-7.53%)
At close: Aug 15, 2025, 3:59 PM
39.27
3.81%
After-hours: Aug 15, 2025, 07:32 PM EDT

LENZ Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5M n/a 66K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 36K 33K 10K 18K 5K 142K 800K 2.1M 2.22M 2.22M 2.17M 2.06M 1.89M n/a 556K 100K 90K
Gross Profit
5M -36K 33K -10K -18K -5K -142K -800K -2.1M -2.22M -2.22M -2.17M -2.06M -1.89M n/a -556K -100K -90K
Operating Income
-16.86M -16.93M -15.22M -12.95M -14.35M -16.09M -14.6M -13.68M -20.96M -23.87M -26.75M -26.15M -26.78M -25.96M -18.94M -14.6M -17.53M -9.37M
Interest Income
2.25M 2.32M 2.57M 2.74M 2.46M 788K 2.56M 2.96M 251K 2.59M 2.15M 1.47M n/a n/a n/a n/a n/a n/a
Pretax Income
-14.41M -14.62M -12.65M -10.21M -10.25M -16.65M -22.92M -22.48M -55.31M -23.93M -24.6M -24.68M -26.66M -26.14M -18.93M -14.59M -17.53M -19.71M
Net Income
-14.91M -14.62M -12.65M -10.21M -10.25M -16.65M -22.92M -22.48M -55.31M -23.93M -24.6M -24.68M -26.66M -26.14M -18.93M -14.59M -17.53M -19.71M
Selling & General & Admin
12.8M 11.11M 9.36M 6.48M 7.39M 5.55M 14.46M 10.49M 5.36M 5.4M 8.29M 7.85M 6.93M 5.82M 7.74M 5.36M 4.77M 3.9M
Research & Development
9.06M 5.82M 5.87M 6.45M 6.95M 10.54M 1K 2.38M 13.51M 16.24M 16.24M 16.13M 17.78M 18.25M 11.21M 8.68M 12.67M 5.38M
Other Expenses
n/a n/a -25K n/a n/a n/a n/a n/a -18K -54K 1K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
21.86M 16.93M 15.2M 12.94M 14.33M 16.09M 14.46M 12.88M 18.86M 21.65M 24.53M 23.99M 24.71M 24.07M 18.94M 14.05M 17.43M 9.28M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
21.86M 16.93M 15.22M 12.95M 14.35M 16.09M 14.6M 13.68M 20.96M 23.87M 26.75M 26.15M 26.78M 25.96M 18.94M 14.6M 17.53M 9.37M
Income Tax Expense
500K n/a 1K n/a n/a n/a -179K n/a n/a 2.18M 303K n/a n/a n/a -71.39K n/a n/a n/a
Shares Outstanding (Basic)
28.08M 27.53M 27.49M 27.17M 25.61M 4.72M 8.29M 8.18M 8.11M 7.98M 7.96M 7.89M 7.8M 7.72M 8.29M 8.3M 8M 8.3M
Shares Outstanding (Diluted)
28.08M 27.53M 27.49M 27.17M 25.61M 4.72M 8.29M 8.18M 8.11M 7.98M 7.96M 7.89M 7.8M 7.72M 8.29M 8.3M 8M 8.3M
EPS (Basic)
-0.53 -0.53 -0.46 -0.38 -0.4 -3.53 -2.77 -2.75 -6.82 -3 -3.09 -3.13 -3.42 -3.39 -2.28 -1.76 -2.19 -2.38
EPS (Diluted)
-0.53 -0.53 -0.46 -0.38 -0.4 -3.53 -2.77 -2.75 -6.82 -3 -3.09 -3.13 -3.42 -3.39 -2.28 -1.76 -2.19 -2.38
EBITDA
-16.84M -16.89M -15.2M -12.94M -14.33M -16.08M -22.78M -21.68M -14.96M -21.65M -24.53M -22.51M -24.6M -24.25M -18.94M -14.04M -17.43M -19.62M
EBIT
-16.86M -16.93M -12.65M -10.21M -10.25M -16.09M -22.92M -19.86M -14.96M -12.62M -9.13M -24.68M -26.66M -26.14M -18.93M -14.59M -17.53M -19.71M
Depreciation & Amortization
19K 36K 25K 10K 18K 5K 142K 800K 2.1M 2.22M 2.22M 2.17M 2.06M 1.89M 71.39K 556K 100K 90K